Germany's Health Reform Law Stumbles Through Parliament
Measure will curtail manufacturer latitude on drug pricing, especially for new drugs not shown to have added benefit over existing products.
Measure will curtail manufacturer latitude on drug pricing, especially for new drugs not shown to have added benefit over existing products.